Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician.

Autor:	Florez N; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Karmo M; HEAL Center of Excellence, Tigerlily Foundation, George Mason University, Fairfax, Virginia., Beltrán Ponce S; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI., Barry MM; Division of Hematology and Oncology, Lerner College of Medicine at the University of Vermont, Burlington, VT., Henry E; Department of Medicine, Edward Hines Jr VA Hospital, Loyola University Stritch School of Medicine, Maywood, IL., Katz MS; Department of Radiation Medicine, Lowell General Hospital, Lowell, MA., Dizon DS; Department of Medicine, Warren Alpert Medical School, Lifespan Cancer Institute, and Legoretta Cancer Center at Brown University, Providence, RI., Hylton HM; K Health, New York, NY.
Jazyk:	angličtina
Zdroj:	JCO oncology practice [JCO Oncol Pract] 2022 Aug; Vol. 18 (8), pp. 572-577. Date of Electronic Publication: 2022 Jul 14.
DOI:	10.1200/OP.21.00762
Abstrakt:	Despite their increased enrollment into medical school, women still face systemic barriers in medicine, whether in an academic or nonacademic setting. Those from Under-Represented Minority (URM) groups face similar issues, which may affect their desire to enter, pursue, and/or maintain a career in medicine. Social media provides unique opportunities for peer-to-peer support among members of URM communities and for amplification of their voices calling for social justice-here defined as a redistribution of power and the quest for equity in access to opportunities, including access to mentorship, professional development, and timely promotion in academic rank. These issues are relevant to oncologists especially as we strive for diversity, equity, and inclusion and to ensure that our patients have equal access to care, regardless of their circumstances. In this article, we review current literature that highlights issues faced by women and historically URM groups in medicine, particularly in oncology. We also discuss the physician's role as a social justice advocate and the concept of the public physician. Competing Interests: Narjust FlorezConsulting or Advisory Role: AstraZeneca, Pfizer, NeoGenomics Laboratories, Janssen, Bristol Myers Squibb/Medarex, Merck, Mirati TherapeuticsSpeakers' Bureau: MJH Life Sciences Maimah KarmoConsulting or Advisory Role: Seattle Genetics, Bayer, Lilly (Inst) Elizabeth HenryEmployment: theMednetConsulting or Advisory Role: Seattle Genetics/AstellasResearch Funding: Seattle Genetics/Astellas (Inst), Bristol Myers Squibb (Inst), Nektar (Inst)Other Relationship: theMednet Matthew S. KatzEmployment: Radiation Oncology AssociatesStock and Other Ownership Interests: Dr Reddy's Laboratories, Healthcare Services Group, CVS Health, Hologic, PfizerOpen Payments Link: https://openpaymentsdata.cms.gov/physician/1027599 Don S. DizonThis author is a member of the Journal of Oncology Practice Editorial Board. Journal policy recused the author from having any role in the peer review of this manuscript.Consulting or Advisory Role: i-Mab, Clovis Oncology, AstraZeneca, Regeneron, Tesaro, Pfizer, Oasmia Pharmaceutical ABResearch Funding: Bristol Myers Squibb (Inst), Kazia Therapeutics (Inst), Pfizer (Inst)Open Payments Link: https://openpaymentsdata.cms.gov/physician/744193/summary Heather M. HyltonThis author is a member of the Journal of Oncology Practice Editorial Board. Journal policy recused the author from having any role in the peer review of this manuscript.No other potential conflicts of interest were reported.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu